Loading…

Tobacco Regulatory Research: Agent

Select Protocol ID

National Health Interview Survey (NHIS), sample adult cancer supplement questionnaire, 2000
#730101

Tobacco Laboratory, Nicotine (Total and Unprotonated), Version 03
#730301

National Adult Tobacco Survey (NATS), 2009 and the Population Assessment of Tobacco and Health (PATH) Survey, 2009-2010
#730401

Massachusetts Benchmark Study (MBS), 1999
#730501

Federal Register Notice, Laboratory measurement, 74 Fed. Reg. 4, Jan. 7, 2009
#730502

National Survey on Drug Use and Health (NSDUH), 2014
#730702

Current Population Survey (CPS), Tobacco Supplement, 2010-2011
#730701

Population Assessment of Tobacco and Health (PATH) Study: Final Adult Interview, Wave 7 (January 2022 - December 2022)
#730704

Kozlowski, L.T., et al, Smokers are unaware of the filter vents now on most cigarettes: results of a national survey. TOB CONTROL, 1996
#730801

Population Assessment of Tobacco and Health (PATH) Study: Final Adult Interview, Wave 7 (January 2022 - December 2022) & International Tobacco Control 4-Country Survey, 2015
#730902
Release Date:

June 24, 2015

Scope of Collection
Element Considered Final Measures in Toolkit
Brand and variety Tobacco Brand and Variety - Cigarettes
Tobacco Brand and Variety - Cigars
Tobacco Brand and Variety - Smokeless Tobacco
Consumption measurements Quantity, frequency, duration used
Abuse liability Constituents that enhance abuse liability, for example
Product adulteration Tobacco Product Adulteration - Vent or Filter Blocking
Product appeal
Product constituents Nicotine Content
Product emissions
Product characterization
Product physical assessments / product design features Physical Properties of Tobacco Products - Cigarettes and Filtered Cigars
Physical Properties of Tobacco Products - Smokeless Tobacco
Topography measures
Toxicology
Warning label awareness and exposure Passive Exposures to Tobacco Products
Working Group Roster:

WG Members:

Richard J. O'Connor, PhD, Co-Chair
Roswell Park Cancer Institute
Department of Health Behavior
Buffalo, NY
Clifford H. Watson, PhD, Co-Chair
Centers for Disease Control and Prevention
Atlanta, GA
Marielle C. Brinkman
Battelle Memorial Institute
Columbus, OH
Barry G. Green, PhD
Yale University
Biological and Biomedical Sciences
New Haven, CT
David Hammond, PhD, MSc
University of Waterloo
School of Public Health and Health Systems
Waterloo, Ontario, Canada,
James F. Pankow, PhD
Portland State University
Portland, OR
Irina Stepanov, PhD
University of Minnesota, Twin Cities
Masonic Cancer Center Division of Environmental Health Sciences
Minneapolis, MN

Tobacco Regulatory Research Panel Liaison, WG Manager and WG Supervisor:

Neal L. Benowitz, MD, Tobacco Regulatory Research Panel Liaison
University of California, San Francisco
San Francisco, CA
Dana M. van Bemmel, PhD, MPH, Tobacco Regulatory Research Panel Liaison
Food and Drug Administration (FDA)
Center for Tobacco Products
Silver Spring, MD
Destiney Nettles, MPM, WG Supervisor
RTI International
Research Triangle Park, NC
Rebecca Geisler, WG Manager
RTI International
Research Triangle Park, NC

FDA Center for Tobacco Products Liaison:

Tricia Johnson, MA
Food and Drug Administration (FDA)
Center for Tobacco Products
Silver Spring, MD

National Institute on Drug Abuse Liaison:

Kevin M. Walton, PhD
National Institute on Drug Abuse (NIDA)
Rockville, MD

Supplemental Information includes protocols that the Working Group or Expert Review Panel considered useful and highly relevant to the domain but do not meet the criteria for inclusion in the Toolkit.

Tobacco Regulatory Research: Agent Supplemental Information includes:
Additional Information:

There is no additional information for this collection.